What Web and SaaS Development Means for a Healthtech Product
Web and SaaS development for a healthtech product has requirements that do not exist in any other sector. NHS Digital Data Security and Protection Toolkit compliance requires specific technical controls around access management, encryption, audit logging, and incident response that a general SaaS architecture may not include by default. GDPR Article 9 for special category health data requires additional safeguards beyond those required for standard personal data processing. DTAC technical security domain requirements include a penetration test and evidence of secure development practices. HL7 FHIR interoperability standards are increasingly required for products that need to connect to NHS systems. DCB0129 clinical safety standards require an audit trail of clinically significant product actions. None of these are optional for a product targeting NHS deployment. A healthtech SaaS product that is built to general commercial SaaS standards will need significant rearchitecting before it can pass NHS data security due diligence. We build healthtech SaaS products to NHS standards from the start, not as a subsequent remediation exercise. This does not mean the product is slower to build or more expensive to maintain. It means the architecture decisions made during the initial build reflect the actual compliance requirements, rather than decisions that need to be reversed later at a point when the codebase is larger and the changes are more expensive.
Our Delivery Process for Healthtech SaaS Products
We begin every healthtech SaaS build with a regulatory and standards mapping session. This identifies the NHS frameworks that apply to your product based on its intended purpose, the data it processes, and the NHS organisations it will be deployed in. The output is a technical requirements list derived from the applicable frameworks, which shapes the architecture decisions in the subsequent scoping session. The technical scoping session then covers the core product functionality, the data model for clinical and administrative data, the authentication and access control approach, the audit logging architecture, the FHIR interoperability requirements if applicable, and the AI features if the product includes them. We review comparable products' DTAC evidence and NHS procurement questionnaire responses during this session to ensure we are scoping for the actual requirements of NHS deployment, not a theoretical version. Development proceeds in weekly cycles with a staging environment accessible to clinical stakeholders throughout. NHS clinical champions and digital health leads who are advising on the product should be able to review working software at each stage, not just wireframes or progress reports. Their feedback during development, rather than at a review at the end, catches clinical workflow assumptions that do not match clinical reality before they are expensive to change. GDPR Article 9 technical controls are implemented from the first sprint: data minimisation, access controls, encryption at rest and in transit, retention controls, and audit logging for access to patient data. These are not added as a compliance layer at the end. They are the default design pattern for any field that contains health data.
Deliverables for a Healthtech SaaS Build
At handover, you receive the complete healthtech SaaS product deployed on UK-based infrastructure, with source code, clinical governance documentation, and NHS compliance evidence materials. The clinical governance documentation covers the audit log architecture and what is logged for clinical governance purposes, the access control model and how it maps to clinical roles, the data model for patient and clinical data with the GDPR Article 9 legal basis for each data category, and the retention policies for clinical and administrative data. The NHS compliance evidence materials are structured to contribute to DTAC assessment across the five domains: clinical safety, data protection, technical security, interoperability, and usability. We do not guarantee DTAC assessment outcomes, but we structure the evidence in the form that DTAC assessors look for and document the design decisions that evidence each domain's requirements. The technical security documentation includes the secure development practices used during the build, the dependency management approach, the input validation and injection prevention measures, the encryption configuration, and the access control implementation. This documentation supports both DTAC technical security assessment and NHS Digital DSP Toolkit technical assertion evidence. FHIR interoperability implementation, where scoped, includes the FHIR resource definitions, the API endpoints, the authentication mechanism for NHS system connections, and the conformance statement that describes the product's FHIR capability. If FHIR interoperability is deferred from the initial build, the architecture is designed to accommodate it in a subsequent phase without requiring a significant rework.
NHS Data Security Architecture for Healthtech Products
The NHS Digital Data Security and Protection Toolkit has specific technical requirements that shape the architecture of any product that will be deployed by or handle data from NHS organisations. The access management requirements specify that access to patient data must be controlled on a role-based basis, with access logged and regularly reviewed. This means role-based access control is not optional, and the access audit log must be queryable for review purposes. The encryption requirements specify encryption in transit using TLS 1.2 or above and encryption at rest for patient data. These are baseline requirements that a well-built application meets as a matter of course, but the DSP Toolkit requires documentary evidence of implementation rather than an assumption. The incident management requirements specify that the organisation has documented procedures for identifying, reporting, and responding to data security incidents, with specific reporting timelines for incidents involving patient data. The technical configuration of the application needs to support the logging and monitoring that enables timely incident detection. The business continuity requirements specify that critical systems have tested recovery procedures and that the organisation understands its recovery time and recovery point objectives. For cloud-hosted healthtech products, the architecture decisions around multi-region deployment, database backup, and recovery procedures need to be documented against these requirements. The device and removable media requirements address how clinical data can be accessed from devices and whether it can be removed or exported. For web-based healthtech products, this translates into session management controls and data export restrictions that prevent patient data from being extracted inappropriately.
FHIR Interoperability for NHS-Facing Products
HL7 FHIR, Fast Healthcare Interoperability Resources, is the NHS's preferred standard for health data exchange and is increasingly a requirement for products that connect to NHS systems including the NHS App, the NHS Login, the Shared Care Record, and Electronic Patient Record systems from major EPR vendors. For a healthtech SaaS product targeting NHS deployment, FHIR interoperability is either a current requirement or an anticipated future requirement, and the architecture decision about whether to build it now or design for it later has cost implications either way. Building FHIR capability into the product from the start is typically more efficient than retrofitting it onto an existing data model. The FHIR resource structure and the clinical data it encodes needs to be reflected in the product's internal data model for the mapping to be clean. A product built with a data model that does not reflect clinical data standards will need a translation layer that introduces complexity and potential data integrity issues. We scope FHIR capability as an explicit component during healthtech SaaS builds, even when full FHIR implementation is deferred. This means the data model is designed to map cleanly to FHIR resources, the API is designed to be extensible to FHIR endpoints, and the authentication architecture is designed to support SMART on FHIR when NHS system connections are required. The result is a product that can add FHIR interoperability in a subsequent phase without rearchitecting the core data model.
Why Healthtech Founders Choose SpeedMVPs for SaaS Development
Healthtech founders who build their SaaS product with a general agency and then attempt to pass NHS procurement discover the compliance gap at the worst possible moment: when an NHS trust has expressed interest and the sales cycle is active. The cost of remediating a product that was not designed for NHS compliance is substantially higher than building it correctly from the start, and the time cost is worse: remediation work delays an active sales cycle. SpeedMVPs eliminates this problem by building NHS compliance into the architecture from the first sprint. The product that comes out of the build is deployable by NHS organisations without a remediation phase. This does not mean the build takes longer or costs more. It means the architecture decisions are correct from the start rather than needing to be reversed. We also understand the specific evidence that NHS procurement teams and DTAC assessors look for, which means the documentation we produce is directly useful for your NHS engagement process rather than documentation that needs to be translated into NHS-compatible language after the fact. For healthtech founders at early stage who need to demonstrate to NHS clinical champions that the product is built to a standard they can trust, having a codebase that was designed for NHS data security from day one is a commercial advantage, not just a compliance requirement. Get a free consultation at speedmvps.co.uk